ICH works on harmonizing data acceptance from multi-regional drug trials
This article was originally published in SRA
Executive Summary
The International Conference on Harmonisation is working on establishing general principles on how sponsors can plan and design multi-regional clinical trials so as to facilitate the acceptance of data from such studies by multiple regulatory agencies1,2.
You may also be interested in...
Finalized ICH Guide Supports Global Approach To Collecting Genomic Samples, Data During Trials
A new guideline finalized by the International Council for Harmonisation is expected to facilitate global genomic studies by enabling a common understanding of critical underlying parameters.
ICH To Fix Inconsistencies With RCTs, Address Use Of Alternate Designs And Data Sources
The International Council for Harmonisation has proposed major changes to its good clinical practice requirements in a bid to allay concerns about the problems they pose in conducting well-designed randomized trials. The revised GCP framework would also address the increasing diversity of clinical trial designs and data sources.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.